As shown in Fig. 1a, b, PRMT5 mRNA expression levels were enhanced in the two most common NSCLC subtypes, lung adenocarcinoma and lung squamous cell carcinoma, as determined using RNA sequencing (RNA-seq) transcriptomic data from The Cancer Genome Atlas (TCGA) database40. This evidence concerns the gene PRMT5 and lung adenocarcinoma.